Introduction

World-Wide Webinar Series: Impact of Modeling & Simulation in Drug Development

This series aims to foster the use of Modeling and Simulation (M&S). Each session will demonstrate how M&S can support product discovery, development, or marketing programs. The series is intended for project team members, including pharmacologists, ADME scientists, PK/PD modelers, clinical pharmacologists, clinicians, regulatory affairs specialists, and Chief Medical and Scientific Officers.

Webinars are free, live sessions that include presentation and discussion sessions. Archived webinars

 

Jul 13, 2016

Session 1: 10 am EDT

Session 2: 2 pm EDT

 

Sep 14, 2016

12:00-1:00 EDT

 

  • TBD
  • Helen Moore, Ph.D., Associate Director, Quantitative Clinical Pharmacology,
    Bristol-Myers Squibb; New York City, NY

Oct 12, 2016

12:00-1:00 EDT

 

Nov 16, 2016

12:00-1:00 EST

 

  • TBD
  • Craig Thalhauser, Ph.D., Associate Director/Quantitative Clinical Pharmacology, Bristol-Myers Squibb, New York City, NY

Jan 18, 2017

12:00-1:00 EST

 

Feb 15, 2017

12:00-1:00 EST

 

  • TBD 
  • Stacey Tannenbaum, PhD, FISoP; Director: Pharmacokinetics, Modeling, and Simulation, Clinical Pharmacology & Exploratory Development; Astellas Pharma Global Development; Northbrook, IL